Bank of America
OPTR

Bank of America’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bank of America’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,659
Closed -$21K – 8580
2013
Q3 		$21K Sell
1,659
-9,424
-85% -$125K ﹤0.01% 6877
2013
Q2 		$160K Buy
+11,083
New +$161K ﹤0.01% 5831

Bank of America's OPTR Position: Q4 2013 in Review

Bank of America sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,659 shares — an estimated $21K sold.

Bank of America first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $160K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Bank of America reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Bank of America sold 1,659 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $21K.
  • Bank of America first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Bank of America's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $160K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Bank of America's 13F filing for Q4 2013, filed 18 Feb 2014.